Statement by Michael A. Carrier to Senate Judiciary Committee
Senate Judiciary Committee hearing May 7, 2019
2 Pages Posted: 29 May 2019
Date Written: May 07, 2019
Abstract
My testimony supports 5 bills that would address anticompetitive games brand drug companies play to delay generic entry: 1) sample denials, 2) pay-for-delay settlements, 3) citizen petitions, 4) product hopping, and 5) patent thicketing.
Keywords: drugs, pharmaceuticals, antitrust, samples, settlements, citizen petitions, product hopping, patent thicketing
JEL Classification: I18, K21, L40, L41, L43, L65, O34, O38
Suggested Citation: Suggested Citation
Carrier, Michael A., Statement by Michael A. Carrier to Senate Judiciary Committee (May 07, 2019). Senate Judiciary Committee hearing May 7, 2019, Rutgers Law School Research Paper, Available at SSRN: https://ssrn.com/abstract=3389822
Do you have negative results from your research you’d like to share?
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.